Write a reviewFor vendors
♡
Home / Investors / andrew sinclair

andrew sinclair

Venture Fund · Royal Tunbridge Wells

About andrew sinclair

Venture capital investor (Managing Director) based in Royal Tunbridge Wells, United Kingdom. Focus areas include Health Care, Autoimmune Diseases, Wellness. Invests at series b stage. Past investments include Kesios Therapeutics, Spruce Biosciences, Amarin.

Investment focus

Stages
Series B
Sectors
Health CareAutoimmune DiseasesWellnessWomen FoundedFundraisingInvestment ManagementStrategic PartnershipsLife SciencePortfolio ManagementFinanceBiotechnologyDrug DevelopmentClinical TrialsGene TherapyVaccinesUK-based StartupsRegulatory ComplianceMedicalB2BTherapeutics

Portfolio

No portfolio companies recorded yet; andrew sinclair reports 60 investments overall.

Similar investors

Aakash Tulsani

Venture Fund · Singapore
Series BHealth CareHospitalsE-commerceSports+16
60Investments
—Exits

Aaref Hilaly

Angel Investor · San Francisco
SeedSeries BEarly Stage VentureSeries AHealth CareData IntegrationTalent ManagementE-commerce+16
60Investments
—Exits

Aaron Goldman

Venture Fund · New York City
Series BHealth CareTalent ManagementE-commerceWellness+16
60Investments
—Exits

Adam Goulburn

Venture Fund · New York City
Series BHealth CareRegenerative MedicineDrug DiscoveryData Science+16
60Investments
—Exits

Adam Greene

Venture Fund · New York City
Series BHealth CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)+14
60Investments
—Exits

Adam Margolin

Venture Fund · Boston
Series BAdvertisingHealth CareWearablesE-commerce+16
60Investments
—Exits